20211102-DSCF6768-Edit.jpg

Welcome! Our research is multidisciplinary and strongly relies on synthetic organic chemistry and biophysical techniques (e.g. DSF/DSC, ITC, NMR spectroscopy), combined with chemical/structural biology and computational methods (e.g. docking, QM). Our primary focus is on the development of chemistry driven approaches to modulate proteins’ physiological activity in a wide sense, with the ultimate goal to deliver new tools to study proteins’ function in living systems. Whenever possible, we exploit the knowledge gained from these studies to attempt tackling difficult problems in human health, notably in cancer, in collaboration with teams of biologists. 

Science 2014 paper graphical abstract (1

Group News:

May 2022: Our new paper describing a Biophysical survey of small-molecule β-Catenin inhibitors - a cautionary tale is now published in the  Journal of Medicinal Chemistry.

Mikes paper graphical absrtact.jpeg

May 2022: The group attends the RSC Chemical Biology Symposium 2022 where both Laura and Ruxy deliver posters on their research on "Bioorthogonal chemistry methodologies and chemical biology of cysteine redox signalling" and "Heteroaromatic sulfones as warheads for Targeted Covalent Inhibitors" respectively. Well done!

MicrosoftTeams-image (7).png
Group picture rsc.jpg
MicrosoftTeams-image (6).png

April 2022: Niama delivers a presentation on her work at the 2022 International MSD Scientific and Family Conference (28-30th April 2022) "Lead Optimisation of Small Molecule Sulfatase Reactivators: Towards a Therapy for Multiple Sulfatase Deficiency". Well done!

April 2022: Ruxy delivers a poster on her research at the University of Southampton Institute for life sciences poster exhibition (28th April 2022) "Heteroaromatic sulfones as warheads for Targeted Covalent Inhibitors".

MicrosoftTeams-image (4).png

April 2022: Ruxy delivers a presentation on her work at the 2022 RSC Chemical Biology and Bio-Organic Group Postgraduate Symposium (4th April 2022) "Heteroaromatic sulfones as warheads for Targeted Covalent Inhibitors". Well done!

MicrosoftTeams-image (1).png
MicrosoftTeams-image (2).png

April 2022: Laura presented a poster on her research on cysteine redox signalling at the 2022 RSC Chemical Biology and Bio-Organic Group Postgraduate Symposium (4th April 2022). View her poster here

MicrosoftTeams-image (3).png

March 2022: Our 4th year project student Akil won first prize for his poster at the undergraduate chemistry poster presentations on his project on Lead Optimisation of Small Molecule Sulfatase Reactivators. Well done! 

February 2022: Matt's book chapter on spirocycles in medicinal chemistry now published in Spiro Compounds: Synthesis and Applications (Wiley).

February 2022: Matt is promoted to Associate Professor.

20191211-DSCF0069.jpg

October 2021: We welcome Suyin Pan to the group for his MPhil project!

October 2021: We welcome Akil and Nomagugu to the group for their Y4 and Y3 undergraduate research projects!

August 2021: Mike presented a poster on his research on Wnt drug discovery at the International Symposium on Synthesis and Catalysis 2021 (31st August- 3rd September 2021). View his poster here and video here
Niama also presented a poster on her research into the medicinal chemistry of multiple sulfatase deficiency. View her poster here

20211102-DSCF6865.jpg

December 2020: Joe presented a poster on his research into p53 drug discovery at the 14th RSC Biological and Medicinal Chemistry Sector Postgraduate Symposium (6-11th December 2020) where he won the Delegates Choice Prize. Well done Joe! View his poster here.

October 2020: New critical review on Current strategies for the design of PROTAC linkers published in collaboration with AstraZeneca, now online in Exploration of Targeted Anti-Tumor Therapy. 

MicrosoftTeams-image.png

October 2020: Steve delivers a presentation on his work at the annual "Kerkut Trust Summer Meeting", which this year took place online: "Small molecule modulation of the wnt pathway: Protein-protein interaction networks and therapeutic outlook". Well done!

October 2020: We welcome Ryan and Danielle to the group for their Y4 and Y3 undergraduate research projects!

September 2020: We welcome Niama and Johanna to the group as PhD students! 

August 2020: New mini-review on p53 drug discovery published in collaboration with the Bulatov lab, now online in Frontiers in Oncology.

Key players in the mutant p53 team.png

July 2020: We welcome to Tuncay the group for his MSc three-month project! 

March 2020: Group social - Cheese and wine night

Cheese Board

February 2020: Group social - Pancake Day

87848721_237993067370089_866862607226424

February 2020: Group social - Escape Room

team-photo-1.jpg

December 2019: Group social - Christmas Meal joint with the Thompson group

81551021_742345469596555_592023531940741

December 2019: Secret Santa

IMG_0187.JPG

October 2019: We welcome Megan, Oliver and Marcin who have joined the group for their Y4 and Y3 undergraduate research projects, respectively.

October 2019: We welcome Jason who has joined the group for his masters research project.

October 2019: We welcome Laura and Ruxandra who have joined the group as PhD students!

July 2019: We welcome Maeva who has joined the group as a postdoc.

May 2019: Steve presents his work at the IFLS-Chemistry for life session at the University of Southampton.

April 2019: The group attend the RSC Chemical Biology Symposium in Southampton. Joe presented a poster on PhD work on p53 drug discovery.

JSC RSC Chem Bio Symposium May 2019.jpg

March 2019: Matt talks at the 2019 Chemical Biology and Bio-Organic Group (CBBG) Forum in Manchester.

April 2018: Our new paper describing chemical probes of the p53-cancer mutant Y220C is now published in the European Journal of Medicinal Chemistry.

Eur J Med chem 2018 graphical abstract.j

October 2018: We welcome Dominique, Johanna and Brad who have joined the group for their Y4 and Y3 undergraduate research projects, respectively.

October 2018: We welcome Sam who has joined the group for his masters research project.

October 2018: We welcome Rob and Steve who have joined the group as PhD students!

 

September 2018: Matt and Mike attend the European Wnt Meeting 2018, fantastic meeting! Mike presented his PhD work on Wnt drug discovery and delivered a flash talk, great job!

Mike presenting.jpg
Conference picture.jpg

August 2018: New challenge! Our group undertakes new research towards tackling Multiple Sulfatase Deficiency, a rare and incurable disease. MSD Action Foundation and the Baud/Dierks/Radhakrishnan/Schlotawa labs join forces to advance research towards a much needed treatment for MSD.

January 2018: New paper on “Optimization of a “bump-and-hole” approach to allele-selective BET bromodomain inhibition” in collaboration with the Ciulli lab is now published in Chemical Science. 

Bump and hole.jpg

October 2017: We welcome Izzy and Amelia who have joined the group for their Y4 and Y3 undergraduate research projects, respectively.

October 2017: We welcome Joe and Mike who have joined the group as PhD students!

August 2017: New paper on “Gram scale laboratory synthesis of TC AC 28, a high affinity BET bromodomain ligand” in collaboration with the Ciulli lab is now published in ACS Omega. 

Gram scale lab synthesis.gif

November 2016: Matt received the 2016 BACR/Astex Roger Griffin Prize for “the best paper on cancer drug discovery” in recognition of the “Bump and Hole” approach to target BET bromodomains, and delivered a talk at the NCRI Cancer Conference 2016, Liverpool.

Guy.jpg

The late Professor Roger Griffin 

namesake of the awarded prize.

matt prize awarding.jpg
NCRI.jpg
astex.png
bacr.png

October 2016: New paper! “Toward photopharmacological antimicrobial chemotherapy using photoswitchable amidohydrolase inhibitors” in collaboration with the Fuchter lab is now published in ACS Infectious Diseases. Well done!

Towards photopharmacological.gif

October 2016: We welcome Phoebe and Rory who have joined the group for their Y4 and Y3 undergraduate research projects, respectively.

September 2016: The Baud group is established in Southampton!

Life sciences building.jpg
kisspng-university-of-southampton-logo-o

November 2021: Congratulations to the newly titled Dr. Joseph Stephenson Clarke who passed his PhD viva on the 8th November! Well done Joe! Good luck on the next stage of your career as a Senior Scientist in Drug Discovery at Evotec!

January 2022: Rob’s review on PROTAC design wins the ETAT Highly Cited Paper Award 2020-2021, well done! Most read/downloaded/cited ETAT article, details here, Exploration of Targeted Anti-tumor Therapy (explorationpub.com)

Research in our laboratory is kindly supported by the following agencies and funding programs:

kisspng-university-of-southampton-logo-o
logo.png
life_arc_logo.png
rosetrees trust.png
MSDlogos-1000x292px-v2.png
AstraZeneca_logo_Astra_Zeneca.png
GK.jpg
HRB.png
UKRI_EPSR_Council-Logo_Horiz-RGB.png
mrc.png
Royal-Society-Logo.jpg
BBSRC-horiz_logo-blue.png
EgfzJIbVkAEWhTj.jpg
YcGoXbBF_400x400.jpg